Search results
Results from the WOW.Com Content Network
Dementia-like symptoms have been found in some individuals who have been exposed to glucocorticoid medication, often dispensed in the form of asthma, arthritis, and anti-inflammatory steroid medications. The condition reverses, but not always completely, within months after steroid treatment is stopped. [2]
Symptoms of glucocorticoid deficiency (having not enough hormones that are classified as glucocorticoids, and mostly consisting of cortisol) vary depending on the underlying cause and severity—common signs and symptoms may include fatigue, weakness, weight loss, decreased appetite, low blood pressure, salt cravings, dizziness upon standing (orthostatic hypotension), muscle aches and pains ...
It is sometimes associated with weight loss. [2] Diabetes most commonly causes damage to the long nerves that supply the feet and lower legs, causing numbness, tingling and pain (diabetic polyneuropathy). Although these symptoms may also be present, the pain and weakness of proximal diabetic neuropathy often onset more quickly and affect nerves ...
Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well Novo Nordisk's rival medicines Ozempic and Wegovy are being studied to see whether they can improve health ...
List of medical symptoms. Medical symptoms refer to the manifestations or indications of a disease or condition, perceived and complained about by the patient. [1] [2] Patients observe these symptoms and seek medical advice from healthcare professionals.
Common symptoms associated with low thyroid function can then include fatigue, cold sensitivity, dry skin, hair loss, constipation, mental fog, menstrual irregularities, and weight gain, he says.
Metabolic syndrome is a clustering of at least three of the following five medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL). Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. [1]
* Eli Lilly's tirzepatide, a GLP-1 therapy sold as Mounjaro for diabetes and Zepbound for weight loss, is being evaluated in a mid-stage study of chronic kidney disease in patients with obesity ...